Characterization of vascular smooth muscle progenitor cells in human peripheral blood
人外周血中血管平滑肌祖细胞的表征
基本信息
- 批准号:12670680
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Vascular smooth muscle cells (SMC) play an important role in human vascular diseases, including atherosclerosis, restenosis after angioplasty, transplant vasculopathy, and angiogenesis by producing extracellular matrix (ECM) proteins and proliferation. It has been believed that intimal SMC are migrated from media and they exhibit immature and inflammatory phenotype in human vascular lesions. Recently, we have demonstrated that circulating bone marrow-derived smooth muscle progenitor cells are involved in pathogenesis of neointimal hyperplasia in mouse aortic transplantation model, thus we gypothesized that vascular smooth muscle progenitor cells could exist in human peripheral circulation, contributing to human vascular fibroproliferative deseases. We cultured human peripheral blood mononuclear cells (PBMC) on ECM-coated plates in SMC-culture media and evaluated cellular phenotype by gene expression profiles. We first discovered expression of vascular smooth muscle α-actin (SM α-actin) … More , an essential vascular SMC marker, in circulating PBMC by RT-PCR, indicating the presence of "vascular smooth muscle progenitor cells" in human peripheral circulation. The SM α-actin positive cells were abundant in low-density PBMC faction (d<1.071 mg/mL) and the expression level of SM α-actin in PBMC varied substantially among donors. Large spindle-shaped, overlayered, SM α-actin-expressing cells ; "MC-like fibromuscular cells (FMC)" were cultured from the low-density PBMC. The SM-α-actin expression in PBMC-derived FMC increased during one month culture period. We confirmed expression of vascular SM α-actin in PBMC-dirived FMC by RT-PCR, Western blotting and immunostaining with a specific monoclonal antibody against SM α-actin (1A4). The PBMC-derived FMC had great ability of proliferation and express major SMC markers ; vimentin, SM22α, SM-1, and partially SM-2 during in vitro culture. Furthermore, they express ECM proteins, type-I and type-III collagen. These results provide a novel concept that "vascular smooth muscle progenitor cells" exist in human circulating peripheral blood and they could potentially contribute to pathogenesis of human vascular diseases and angiogenesis from luminal blood stream Less
血管平滑肌细胞(SMC)通过产生细胞外基质(ECM)蛋白和增殖,在动脉粥样硬化、血管成形术后再狭窄、移植血管病变和血管生成等人类血管疾病中发挥重要作用。已有研究认为,血管内膜SMC是从中膜中迁移出来的,在人类血管病变中表现出不成熟和炎性表型。最近,我们证实了循环中的骨髓源性平滑肌前体细胞参与了小鼠主动脉移植模型新生内膜增生的发病过程,从而推测血管平滑肌前体细胞可能存在于人外周循环中,参与了人类血管纤维增生性疾病的发生。我们将人外周血单个核细胞(PBMC)培养在SMC培养液中的ECM涂层平板上,并通过基因表达谱来评估细胞表型。首次发现血管平滑肌α-肌动蛋白(SMα-Actin)…的表达此外,一个重要的血管SMC标志物,通过RT-PCR在循环PBMC中的表达,表明在人的外周循环中存在“血管平滑肌前体细胞”。低密度(d<;1.071 mg/mL)外周血单核细胞中SMα-肌动蛋白阳性细胞较多,不同供者外周血单个核细胞SMα-肌动蛋白表达水平差异很大。从低密度的外周血单核细胞中培养出大的梭形、复层的SM-α-肌动蛋白表达细胞;在1个月的培养过程中,SM-α-肌动蛋白的表达增加。我们用RT-PCR法、Western blotting和抗SMα-Actin(1A4)的特异性单抗免疫染色证实了血管SMα-Actin在PBMC诱导的系膜细胞中的表达。体外培养条件下,骨髓间充质干细胞具有较强的增殖能力,并表达主要的平滑肌细胞标志物:波形蛋白、SM22α、SM-1和部分SM-2。此外,它们还表达ECM蛋白、I型和III型胶原。这些结果提供了一个新的概念,即“血管平滑肌前体细胞”存在于人类循环外周血中,它们可能在人类血管疾病的发病机制和血管新生中起重要作用。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Seigo Sugiyama: "Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atheroschlirosis"American Journal of Pathology. 158. 879-891 (2001)
Seigo Sugiyama:“人类动脉粥样硬化中粒细胞巨噬细胞集落刺激因子对巨噬细胞髓过氧化物酶的调节”美国病理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
KOICHI SHIMIZU: "Host bone-marrow cells are a source of donor intimal smooth-muscle like cells in murine aortic transplant arteriopathy"NATURE MEDICENE. Vol.7. 738-741 (2001)
清水晃一:“宿主骨髓细胞是小鼠主动脉移植动脉病中供体内膜平滑肌样细胞的来源”《自然医学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN.: "Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy"Nat Med. 7. 738-41 (2001)
Shimizu K、Sugiyama S、Aikawa M、Fukumoto Y、Rabkin E、Libby P、Mitchell RN.:“宿主骨髓细胞是小鼠主动脉移植动脉病供体内膜平滑肌样细胞的来源”Nat Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
KOICHI SHIMIZU: "Host bone-marrow cells are a source of donor intimal Smooth-muscle like cells in murine aortic transplant arteriopathy"NATURE MEDICINE. Vol.7. 738-741 (2001)
KOICHI SHIMIZU:“宿主骨髓细胞是小鼠主动脉移植动脉病中供体内膜平滑肌样细胞的来源”《自然医学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seigo Sugiyama: "Characterization of vascular smooth muscle progenitor cells in human peripheral blood"Circulation (Suppl). 104. II 130 (2001)
Seigo Sugiyama:“人外周血中血管平滑肌祖细胞的表征”循环(增刊)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGIYAMA Seigo其他文献
SUGIYAMA Seigo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGIYAMA Seigo', 18)}}的其他基金
Clinical Assessment of Endothelial Dysfunction and Investigationof New Therapies in Cardiovascular Diseases
内皮功能障碍的临床评估和心血管疾病新疗法的研究
- 批准号:
22590786 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study about the Involvement of Metabolic Syndrome and Endothelial Dysfunction in Vulnerable Atherosclerosis
代谢综合征和内皮功能障碍与脆弱性动脉粥样硬化的关系研究
- 批准号:
19590869 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Assessment and Evaluation of Vascular Vulnerability in Patients with Atherosclerosis: Clinical Examination and Application
动脉粥样硬化患者血管脆弱性的评估与评价:临床检查与应用
- 批准号:
17590753 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of Intimal Smooth Muscle Precursor Cells in Circulating Human Peripheral Blood : Potential Origin of Intimal Smooth Muscle Cells in Vascular Lesions
循环人外周血中内膜平滑肌前体细胞的表征:血管病变中内膜平滑肌细胞的潜在起源
- 批准号:
14570679 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis
RNA靶位点寡核苷酸倾斜免疫细胞促进血管平滑肌细胞稳态
- 批准号:
10593490 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Developmental basis for vascular smooth muscle cell dysfunction in Marfan syndrome aortic aneurysm
马凡综合征主动脉瘤血管平滑肌细胞功能障碍的发育基础
- 批准号:
10066295 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Developmental basis for vascular smooth muscle cell dysfunction in Marfan syndrome aortic aneurysm
马凡综合征主动脉瘤血管平滑肌细胞功能障碍的发育基础
- 批准号:
10463538 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
- 批准号:
9894827 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
- 批准号:
10554120 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
- 批准号:
10090617 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of vascular smooth muscle cell differentiation by fatty acid composition
脂肪酸组成对血管平滑肌细胞分化的调节
- 批准号:
16H05294 - 财政年份:2016
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
GOLPH3 in vascular smooth muscle cell biology and vascular disease
GOLPH3 在血管平滑肌细胞生物学和血管疾病中的作用
- 批准号:
9327041 - 财政年份:2016
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of vascular smooth muscle cell plasticity
血管平滑肌细胞可塑性的调节
- 批准号:
8998052 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of vascular smooth muscle cell plasticity
血管平滑肌细胞可塑性的调节
- 批准号:
8630004 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别: